Clinical Trial Update: Oral Paricalcitol in Kidney Transplant Recipients [NA]

View source ↗

Summary

A completed clinical trial evaluated oral paricalcitol in kidney transplant recipients. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperparathyroidism

Drugs mentioned

• Zemplar (Paricalcitol)

Snippet

Sponsor: Mayo Clinic | Conditions: Transplant; Failure, Kidney, Renal Disease, End Stage | NA | Status: COMPLETED | Results posted: 2013-05-08